PUREPATH LAB & THERAPEUTICS, LLC
NPI 1043964257
Clinical Medical Laboratory in Lewisville, TX
NPI Status: Active since February 07, 2022
Contact Information
570 S EDMONDS LN STE 104
LEWISVILLE, TX
ZIP 75067
Phone: (714) 249-0645
- Organization
- Clinical Medical Laboratory
- Accepts Insurance
- CLIA Number: 45D2254743
- CLIA Cert. Type: Independent
- CLIA Exp. Date: 02-09-2027
About PUREPATH LAB & THERAPEUTICS, LLC
This page provides the complete NPI Profile along with additional information for Purepath Lab & Therapeutics, Llc, a provider established in Lewisville, Texas operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1043964257 assigned on February 2022. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 3 years ago. The authorized official of this NPI record is Hemraj Chaudhary (Owner)
- NPI
- 1043964257
- Provider Name
- PUREPATH LAB & THERAPEUTICS, LLC
- Entity Type
- Organization
- Location Address
- 570 S EDMONDS LN STE 104 LEWISVILLE, TX 75067
- Location Phone
- (714) 249-0645
- Mailing Address
- 570 S EDMONDS LN STE 104 LEWISVILLE, TX 75067
- Mailing Phone
- (469) 464-4522
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 02-07-2022
- Last Update Date
- 01-12-2023
- Code Navigator
Establishments like Purepath Lab & Therapeutics, Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Insurance Plans Accepted
According to publicly available information the provider might be accepting the following health plans from these health insurance companies:
- Blue Advantage Bronze HMO? 204 - HMO
- Blue Advantage Bronze HMO? 301 - HMO
- Blue Advantage Bronze HMO? Standard - HMO
- Blue Advantage Gold HMO? 206 - HMO
- Blue Advantage Gold HMO? 603 - HMO
- Blue Advantage Gold HMO? Standard - HMO
- Blue Advantage Plus Bronze? 303 - POS
- Blue Advantage Plus Bronze? 305 - POS
- Blue Advantage Plus Bronze? Standard - POS
- Blue Advantage Plus Gold? 203 - POS
- Blue Advantage Plus Gold? 803 - POS
- Blue Advantage Plus Gold? Standard - POS
- Blue Advantage Plus Silver? 202 - POS
- Blue Advantage Plus Silver? 605 - POS
- Blue Advantage Plus Silver? Standard - POS
- Blue Advantage Security HMO? 200 - HMO
- Blue Advantage Silver HMO? 205 - HMO
- Blue Advantage Silver HMO? 801 - HMO
- Blue Advantage Silver HMO? Standard - HMO
- MyBlue Health Bronze? 402 - HMO
*Please verify directly with this provider to make sure your insurance plan is currently accepted.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen
Detection test by immunoassay technique for multiple organisms, each polyvalent antiserum
Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique
Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique
Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets
Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique
Detection test by nucleic acid for organism, amplified probe technique
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
Detection test for candida species (yeast), amplified probe technique
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants
Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
Testing for presence of drug, by chemistry analyzers
Urinalysis, manual test
This is a lab test that detects the presence of COVID-19 in your body. It uses a technique to amplify the virus's genetic material, either DNA or RNA, making it easier to identify. A positive result indicates an active infection.
This service was performed 200 times for 175 patientsThis test uses a method called immunoassay to identify various organisms in your body. It involves the use of polyvalent antiserum, which can react with multiple types of organisms. This helps in detecting and identifying a wide range of possible infections.
This service was performed 13 times for 13 patientsThis test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.
This service was performed 124 times for 114 patientsThis test identifies the presence of an enterovirus, a type of virus that primarily targets the digestive system. It uses a method called the amplified probe technique to boost the detection of the virus's genetic material, or nucleic acid.
This service was performed 124 times for 114 patientsA detection test for Legionella Pneumophila, a waterborne bacteria, uses the amplified probe technique. This involves identifying the bacteria's unique genetic material (nucleic acid) and amplifying it for easier detection, aiding in accurate diagnosis.
This service was performed 111 times for 102 patientsThis is a test that identifies various microorganisms in your body using a method called amplified probe technique. It targets specific genetic material (nucleic acids) of the organisms, amplifying them for easy detection. This helps in diagnosing infections accurately.
This service was performed 189 times for 48 patientsThis test identifies different respiratory viruses by examining their nucleic acid, the building blocks of their genetic material. It can detect multiple types or subtypes, specifically 3-5 targets. This helps in diagnosing your respiratory illness accurately.
This service was performed 118 times for 109 patientsThis test checks for Mycoplasma pneumoniae, a bacteria that can cause lung infection. It uses a method called amplified probe technique, which identifies the bacteria's genetic material. This helps in diagnosing the infection accurately.
This service was performed 124 times for 114 patientsA nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.
This service was performed 1,806 times for 127 patientsA detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.
This service was performed 187 times for 153 patientsA detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.
This service was performed 145 times for 131 patientsThis test detects Group A Streptococcus bacteria in your body. It uses an amplified probe technique, which amplifies the bacteria's nucleic acid, making it easier to identify. This test helps diagnose conditions like strep throat or scarlet fever.
This service was performed 142 times for 128 patientsA detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.
This service was performed 140 times for 126 patientsThe detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.
This service was performed 202 times for 163 patientsThis test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.
This service was performed 80 times for 18 patientsA definitive drug test is a detailed analysis used to identify specific drugs in your system. It uses advanced techniques, such as gc/ms and lc/ms, to detect and distinguish between different drugs, even those with similar structures.
This service was performed 100 times for 64 patientsA definitive drug test identifies specific drugs in your system. Advanced methods like GC/MS (Gas Chromatography/Mass Spectrometry) and LC/MS (Liquid Chromatography/Mass Spectrometry) are used. These can distinguish between similar drugs, providing precise results.
This service was performed 29 times for 23 patientsGene analysis for 5,10-methylenetetrahydrofolate reductase (MTHFR) common variants is a test that looks at your DNA to identify any changes in the MTHFR gene. These changes can affect how your body processes certain vitamins, which could impact your overall health.
This service was performed 20 times for 20 patientsGene analysis of cytochrome P450 2D6 (CYP2D6) common variants involves studying specific genes to understand your body's ability to process certain medications. This can help tailor treatments to your unique genetic makeup, optimizing medication effectiveness and safety.
This service was performed 18 times for 18 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 601 times for 340 patientsThis is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.
This service was performed 607 times for 341 patientsThis service provides a FDA-approved COVID-19 test kit for personal use. The test is self-administered and self-collected, meaning you conduct the test yourself. The kit contains all necessary items for one test. Follow the instructions carefully to ensure accurate results.
This service was performed 147,538 times for 16,114 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 602 times for 342 patientsChemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.
This service was performed 126 times for 82 patientsA urinalysis is a simple, non-invasive test that checks the urine for various elements such as sugar, protein, and signs of infection. It can help detect many common conditions, including kidney disease and diabetes. The manual test involves a lab technician examining a urine sample.
This service was performed 54 times for 38 patientsCLIA Information
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:
- CLIA Number
- 45D2254743
- Facility Type
- Independent
- Certificate Effective Date
- February 10, 2025
- Certificate Expiration Date
- February 09, 2027
- Laboratory Director
- DR. ANUP R. TILAK
- Certificate Type
- Certificate of Waiver
- Certificate Type Description
- This CLIA certificate is issued to Purepath Lab & Therapeutics, Llc to perform only waived tests. CLIA defines waived tests as simple tests with a low risk for an incorrect result. Waived tests include certain tests listed in CLIA regulations, tests cleared by the FDA for home use and tests approved by the FDA for waived status and that meet CLIA waiver criteria.
Reviews for PUREPATH LAB & THERAPEUTICS, LLC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1043964257, we treat the final digit (7) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 63. The final step is to find the difference between that total and the next multiple of ten (70 - 63 = 7).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 63 is 70. The difference is the calculated check digit.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1043964257, enumerated as an "organization" on February 07, 2022.
The provider is located at 570 S EDMONDS LN STE 104 LEWISVILLE, TX 75067 and the phone number is (714) 249-0645.
Clinical Medical Laboratory with taxonomy code 291U00000X.
The provider might be accepting Accepts: Blue Cross and Blue Shield of Texas. Please consult your insurance carrier or call the provider to verify.